Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2177.94 | 1445 / 1445 | 100% | 19.19 | 183 / 183 |
ovary | 100% | 2396.26 | 180 / 180 | 100% | 14.33 | 430 / 430 |
breast | 100% | 2429.64 | 459 / 459 | 100% | 24.73 | 1116 / 1118 |
prostate | 100% | 2569.40 | 245 / 245 | 100% | 22.28 | 501 / 502 |
lung | 100% | 2070.55 | 577 / 578 | 100% | 18.48 | 1154 / 1155 |
uterus | 100% | 2210.98 | 170 / 170 | 99% | 16.10 | 456 / 459 |
brain | 99% | 1194.97 | 2625 / 2642 | 100% | 17.27 | 704 / 705 |
thymus | 100% | 2323.67 | 653 / 653 | 99% | 14.36 | 600 / 605 |
intestine | 100% | 2121.41 | 966 / 966 | 98% | 13.88 | 519 / 527 |
stomach | 100% | 1422.22 | 359 / 359 | 98% | 14.75 | 280 / 286 |
bladder | 100% | 2373.29 | 21 / 21 | 98% | 13.11 | 493 / 504 |
pancreas | 98% | 887.70 | 320 / 328 | 99% | 13.32 | 176 / 178 |
kidney | 100% | 1423.21 | 89 / 89 | 96% | 14.46 | 862 / 901 |
adrenal gland | 100% | 2083.55 | 258 / 258 | 95% | 11.72 | 218 / 230 |
skin | 100% | 2303.86 | 1808 / 1809 | 95% | 16.53 | 447 / 472 |
liver | 98% | 791.42 | 221 / 226 | 94% | 8.79 | 380 / 406 |
adipose | 100% | 2665.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3197.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.65 | 29 / 29 |
muscle | 100% | 1783.73 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1395.05 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.89 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.70 | 44 / 45 |
heart | 96% | 1597.11 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1696.47 | 892 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 5.24 | 51 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045638 | Biological process | negative regulation of myeloid cell differentiation |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_1902808 | Biological process | positive regulation of cell cycle G1/S phase transition |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0001558 | Biological process | regulation of cell growth |
GO_0031124 | Biological process | mRNA 3'-end processing |
GO_0031442 | Biological process | positive regulation of mRNA 3'-end processing |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0031648 | Biological process | protein destabilization |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
GO_0001711 | Biological process | endodermal cell fate commitment |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016593 | Cellular component | Cdc73/Paf1 complex |
GO_0005829 | Cellular component | cytosol |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CDC73 |
Protein name | Cell division cycle 73 Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein) Cell division cycle 73 Paf1/RNA polymerase II complex component-like protein isoform 2 Cell division cycle 73 Paf1/RNA polymerase II complex component-like protein isoform 1 |
Synonyms | HRPT2 C1orf28 |
Description | FUNCTION: Tumor suppressor probably involved in transcriptional and post-transcriptional control pathways. May be involved in cell cycle progression through the regulation of cyclin D1/PRAD1 expression. Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1; it promotes leukemogenesis through association with KMT2A/MLL1-rearranged oncoproteins, such as KMT2A/MLL1-MLLT3/AF9 and KMT2A/MLL1-MLLT1/ENL. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. In case of infection by influenza A strain H3N2, PAF1C associates with viral NS1 protein, thereby regulating gene transcription. Connects PAF1C with the cleavage and polyadenylation specificity factor (CPSF) complex and the cleavage stimulation factor (CSTF) complex, and with Wnt signaling. Involved in polyadenylation of mRNA precursors. . |
Accessions | ENST00000643006.1 A0A2R8Y640 A0A1B0GUB2 A0A3B3IRP5 Q6P1J9 ENST00000635846.1 A0A0S2Z5N1 A0A2R8YHB3 A0A3B3ISN2 ENST00000648071.1 ENST00000650197.1 A0A0S2Z5M9 ENST00000643784.1 ENST00000367435.5 |